Research priorities for exacerbations of COPD

Jaber S. Alqahtani; Julian Aquilina; Mona Bafadhel; Charlotte E. Bolton; Teresa Burgoyne; Steve Holmes; Joanne King; John Loots; Joan McCarthy; Jennifer K. Quint; Heidi A. Ridsdale; Elizabeth Sapey; Sheela Upadhyaya; Tom M.A. Wilkinson; John R. Hurst

doi:10.1016/S2213-2600(21)00227-7

Research priorities for exacerbations of COPD

Jaber S. Alqahtani, Julian Aquilina, Mona Bafadhel, Charlotte E. Bolton, Teresa Burgoyne, Steve Holmes, Joanne King, John Loots, Joan McCarthy, Jennifer K. Quint, Heidi A. Ridsdale, Elizabeth Sapey, Sheela Upadhyaya, Tom M.A. Wilkinson, John R. Hurst^*

^*Corresponding author for this work

Inflammation and Ageing

Research output: Contribution to journal › Article › peer-review

17 Citations (Scopus)

Original language	English
Pages (from-to)	824-826
Number of pages	3
Journal	The Lancet Respiratory Medicine
Volume	9
Issue number	8
Early online date	14 May 2021
DOIs	https://doi.org/10.1016/S2213-2600(21)00227-7
Publication status	Published - Aug 2021

Bibliographical note

Funding Information:
MB, CEB, TB, JKQ, HAR, ES, TMAW, and JRH were applicants on the original grant to the British Lung Foundation (BLF). MB, CEB, SH, JK, JKQ, ES, TMAW, and JRH have received support to attend meetings, personal payment or payment to their employers for education or advisory work, or academic grants from pharmaceutical companies that make medicines to treat COPD. TMAW is a Director and shareholder at Mymhealth. SU is a JLA PSP Advisor. JSA, JA, JL, and JM have no competing interests. We thank the BLF for funding this research, and all the participants who took part in our surveys and workshops.

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1016/S2213-2600(21)00227-7

https://discovery.ucl.ac.uk/id/eprint/10129578/

Cite this

@article{ffacd24bc47f4317ab6175be55e80898,

title = "Research priorities for exacerbations of COPD",

author = "Alqahtani, {Jaber S.} and Julian Aquilina and Mona Bafadhel and Bolton, {Charlotte E.} and Teresa Burgoyne and Steve Holmes and Joanne King and John Loots and Joan McCarthy and Quint, {Jennifer K.} and Ridsdale, {Heidi A.} and Elizabeth Sapey and Sheela Upadhyaya and Wilkinson, {Tom M.A.} and Hurst, {John R.}",

note = "Funding Information: MB, CEB, TB, JKQ, HAR, ES, TMAW, and JRH were applicants on the original grant to the British Lung Foundation (BLF). MB, CEB, SH, JK, JKQ, ES, TMAW, and JRH have received support to attend meetings, personal payment or payment to their employers for education or advisory work, or academic grants from pharmaceutical companies that make medicines to treat COPD. TMAW is a Director and shareholder at Mymhealth. SU is a JLA PSP Advisor. JSA, JA, JL, and JM have no competing interests. We thank the BLF for funding this research, and all the participants who took part in our surveys and workshops. ",

year = "2021",

month = aug,

doi = "10.1016/S2213-2600(21)00227-7",

language = "English",

volume = "9",

pages = "824--826",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier",

number = "8",

}

TY - JOUR

T1 - Research priorities for exacerbations of COPD

AU - Alqahtani, Jaber S.

AU - Aquilina, Julian

AU - Bafadhel, Mona

AU - Bolton, Charlotte E.

AU - Burgoyne, Teresa

AU - Holmes, Steve

AU - King, Joanne

AU - Loots, John

AU - McCarthy, Joan

AU - Quint, Jennifer K.

AU - Ridsdale, Heidi A.

AU - Sapey, Elizabeth

AU - Upadhyaya, Sheela

AU - Wilkinson, Tom M.A.

AU - Hurst, John R.

N1 - Funding Information: MB, CEB, TB, JKQ, HAR, ES, TMAW, and JRH were applicants on the original grant to the British Lung Foundation (BLF). MB, CEB, SH, JK, JKQ, ES, TMAW, and JRH have received support to attend meetings, personal payment or payment to their employers for education or advisory work, or academic grants from pharmaceutical companies that make medicines to treat COPD. TMAW is a Director and shareholder at Mymhealth. SU is a JLA PSP Advisor. JSA, JA, JL, and JM have no competing interests. We thank the BLF for funding this research, and all the participants who took part in our surveys and workshops.

PY - 2021/8

Y1 - 2021/8

UR - http://www.scopus.com/inward/record.url?scp=85110483108&partnerID=8YFLogxK

U2 - 10.1016/S2213-2600(21)00227-7

DO - 10.1016/S2213-2600(21)00227-7

M3 - Article

C2 - 34000234

AN - SCOPUS:85110483108

SN - 2213-2600

VL - 9

SP - 824

EP - 826

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

IS - 8

ER -